PT ES Get the brief

Glioma Intelligence Hub

Navigating glioma,
together.

This platform began with a personal glioma diagnosis — and the discovery of how scattered and out of reach the research really was. We built Zyntha to change that.

Read the glioma guide Explore the research

Free forever · Written for patients & families · No medical jargon

Abstract visualization of the glioma research field — thousands of studies connected and analyzed in real time

Live research field · updated hourly

4,400Studies tracked

2,500Sources monitored

24/7Live analysis

ClinicalTrials.gov, PubMed, the FDA and thousands of medical sources — read continuously, scored for glioma relevance.

Where would you like to start?

Everything you need, in one place

Tools and information for everyone navigating glioma — from a clear diagnosis guide to the very latest research.

Understanding your diagnosis

A clear guide to gliomas, treatments, and what to expect — no medical degree required.

Read the glioma guide

Research & publications

Curated trials, molecular data, and research trends — organised by clinical significance.

Browse publications

Clinical trials

Explore active trials by condition, location, and treatment type — matched to your subtype.

Search trials

Topographic scan-contour texture representing layers of analysed research

WHO 2021 taxonomy · relevance-scored

How we work

How we keep you informed

We read thousands of global medical sources around the clock, analyse new studies as they emerge, and translate the complex ones into clear, everyday language — so what matters reaches you without the noise.

We monitor

Continuously scanning ClinicalTrials.gov, PubMed, the FDA and thousands of sources for new glioma-relevant research.

We analyse

Every study is classified by the WHO 2021 taxonomy, scored for relevance, and enriched with molecular markers.

You discover

Browse an intelligence dashboard, explore active trials, or read a curated brief — all in clear, everyday language.

Why Zyntha

The information exists.
Now it’s yours.

Behind this platform is a personal diagnosis, a frustration, and a decision. The research was scattered, the resources out of reach. We deserved more — so we built it.

Unlike a traditional trial database, every study here is written for patients and families, updated within hours, and built specifically for the glioma community.

Why this platform

What makes this different

Written without the jargon

Every study, trial, and article is summarised so patients and families can actually understand it.

Updated continuously

Running 24/7 across thousands of sources. New trials and publications appear within hours — not weeks.

Designed for glioma

Built for one community. Every feature — from molecular markers to subtype filters — speaks your language.

Trusted sources

Sourced from the world’s leading institutions

All content comes from peer-reviewed journals, verified trial registries, and top cancer research centres.

ClinicalTrials.govPubMedThe Lancet OncologyNature MedicineFDANCINeuro-OncologyASCOMD AndersonDana-FarberMemorial Sloan KetteringJAMA +108 more

Every article is scored for glioma relevance, classified by the WHO 2021 taxonomy, and summarised in patient-friendly language before it reaches you.

We are not medical professionals. This platform is for educational and research purposes only — always consult your healthcare team for treatment decisions.

Navigating glioma,together.